Beijing Biotech
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Beijing Biotech
RECRUITINGPhase 1 / Phase 2NCT07500220
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
open-label trial of an allogeneic dual-target CAR-NK product directed against GPC3 and B7-H3 for adults with advanced hepatocellular carcinoma. The design intentionally uses GPC3...
Sponsor: Beijing BiotechEnrolling: 301 location
Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer
RECRUITINGPhase 1NCT07492628
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
This hypothetical first-in-human study is designed to evaluate the safety, feasibility, and preliminary anti-tumor activity of an allogeneic dual-target Nectin-4/HER2 CAR-NK cell...
Sponsor: Beijing BiotechEnrolling: 421 location
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2